These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 23849432

  • 21. Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients.
    Asil M, Dertli R.
    Medicine (Baltimore); 2016 Sep; 95(37):e4763. PubMed ID: 27631226
    [Abstract] [Full Text] [Related]

  • 22. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis.
    Blanco-Colio LM, Martín-Ventura JL, Muñóz-García B, Orbe J, Páramo JA, Michel JB, Ortiz A, Meilhac O, Egido J.
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):916-22. PubMed ID: 17272745
    [Abstract] [Full Text] [Related]

  • 23. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.
    Bozic M, Méndez-Barbero N, Gutiérrez-Muñoz C, Betriu A, Egido J, Fernández E, Martín-Ventura JL, Valdivielso JM, Blanco-Colio LM, investigators from the NEFRONA study.
    Atherosclerosis; 2018 Mar; 270():13-20. PubMed ID: 29407881
    [Abstract] [Full Text] [Related]

  • 24. Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study.
    Llauradó G, González-Clemente JM, Maymó-Masip E, Subías D, Vendrell J, Chacón MR.
    PLoS One; 2012 Mar; 7(8):e43919. PubMed ID: 22937125
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.
    Moreno JA, Dejouvencel T, Labreuche J, Smadja DM, Dussiot M, Martin-Ventura JL, Egido J, Gaussem P, Emmerich J, Michel JB, Blanco-Colio LM, Meilhac O.
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1253-62. PubMed ID: 20299688
    [Abstract] [Full Text] [Related]

  • 29. Soluble Tumor Necrosis Factor Like Weak Inducer of Apoptosis and Vitamin D in Hemodialysis Patients: Relation to Carotid Intima-Media Thickness.
    Askarian F, Ghorbanihaghjo A, Argani H, Sanajou D, Nasehi N, Askarian R, Ahmadi R, Rahtchizadeh N.
    Indian J Clin Biochem; 2018 Jul; 33(3):297-303. PubMed ID: 30072829
    [Abstract] [Full Text] [Related]

  • 30. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.
    Kowal-Bielecka O, Bielecki M, Guiducci S, Trzcinska-Butkiewicz B, Michalska-Jakubus M, Matucci-Cerinic M, Brzosko M, Krasowska D, Chyczewski L, Kowal K.
    Arthritis Res Ther; 2013 Jul; 15(3):R69. PubMed ID: 23800379
    [Abstract] [Full Text] [Related]

  • 31. MCP-1 and soluble TWEAK levels are independently associated with coronary artery disease severity in patients with chronic kidney disease.
    Akdoğan MF, Azak A, Denizli N, Huddam B, Koçak G, Gücün M, Tatlısu MA, Demirci R, Yılmaz B, Dikeç M, Bakırtaş M, Akdağ İ, Duranay M.
    Ren Fail; 2015 Jul; 37(8):1297-302. PubMed ID: 26382008
    [Abstract] [Full Text] [Related]

  • 32. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
    Fan WC, Huang CC, Yang YY, Lin A, Lee KC, Hsieh YC, Fung CP, Hsu HC, Hou MC, Lin HC.
    J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435
    [Abstract] [Full Text] [Related]

  • 33. Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk.
    Díaz-López A, Bulló M, Chacón MR, Estruch R, Vendrell J, Díez-Espino J, Fitó M, Corella D, Salas-Salvadó J.
    Cardiovasc Diabetol; 2014 Feb 24; 13():51. PubMed ID: 24565471
    [Abstract] [Full Text] [Related]

  • 34. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis.
    Yurtdaş M, Yaylali YT, Kaya Y, Ozdemir M, Ozkan I, Aladağ N.
    Echocardiography; 2014 Oct 24; 31(9):1095-104. PubMed ID: 24447343
    [Abstract] [Full Text] [Related]

  • 35. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure.
    Ptaszynska-Kopczynska K, Marcinkiewicz-Siemion M, Lisowska A, Waszkiewicz E, Witkowski M, Jasiewicz M, Miklasz P, Jakim P, Galar B, Musial WJ, Kaminski KA.
    Cytokine; 2016 Apr 24; 80():7-12. PubMed ID: 26916171
    [Abstract] [Full Text] [Related]

  • 36. Inter- not intraindividual differences in sTWEAK levels predict functional deterioration and mortality in patients with dilated cardiomyopathy.
    Jarr KU, Nelles M, Katus HA, Chorianopoulos E.
    Mediators Inflamm; 2014 Apr 24; 2014():576482. PubMed ID: 25089077
    [Abstract] [Full Text] [Related]

  • 37. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S, Cinar S, Yazici H, Ozluk Y, Kilicaslan I, Gul A, Ocal L, Inanc M, Artim-Esen B.
    Lupus; 2020 Apr 24; 29(4):379-388. PubMed ID: 32041504
    [Abstract] [Full Text] [Related]

  • 38. Soluble TWEAK levels are independently associated with coronary artery disease severity in patients with stage 2-3 kidney disease.
    Azak A, Akdoğan MF, Denizli N, Huddam B, Koçak G, Gücün M, Tatlısu MA, Demirci R, Yılmaz B, Dikeç M, Bakırtaş M, Akdağ I, Duranay M.
    Int Urol Nephrol; 2014 Feb 24; 46(2):411-5. PubMed ID: 24043442
    [Abstract] [Full Text] [Related]

  • 39. Nitroglycerin mediated dilation evaluated by ultrasound is associated with sTWEAK in hemodialysis patients.
    Rusu CC, Ghervan L, Racasan S, Kacsa I, Moldovan D, Potra A, Bondor C, Anton F, Patiu IM, Caprioara MG.
    Med Ultrason; 2016 Mar 24; 18(1):57-63. PubMed ID: 26962555
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.